Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Change in Acquisitions & Divestments (2017 - 2025)

Historic Change in Acquisitions & Divestments for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to $102.6 million.

  • Protagonist Therapeutics' Change in Acquisitions & Divestments rose 7477.99% to $102.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $444.6 million, marking a year-over-year increase of 7484.7%. This contributed to the annual value of $323.6 million for FY2024, which is 11232.45% up from last year.
  • Per Protagonist Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $102.6 million for Q3 2025, which was up 7477.99% from $122.8 million recorded in Q2 2025.
  • Protagonist Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $122.8 million for Q2 2025, and its period low was $32.0 million during Q2 2023.
  • Over the past 5 years, Protagonist Therapeutics' median Change in Acquisitions & Divestments value was $80.6 million (recorded in 2021), while the average stood at $73.3 million.
  • In the last 5 years, Protagonist Therapeutics' Change in Acquisitions & Divestments plummeted by 6064.59% in 2023 and then surged by 18881.2% in 2024.
  • Over the past 5 years, Protagonist Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $58.8 million in 2021, then skyrocketed by 44.0% to $84.6 million in 2022, then tumbled by 56.62% to $36.7 million in 2023, then soared by 188.81% to $106.0 million in 2024, then fell by 3.15% to $102.6 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $102.6 million for Q3 2025, versus $122.8 million for Q2 2025 and $113.2 million for Q1 2025.